The first fluorogenic sensor for sphingosine-1-phosphate lyase activity in intact cells.

New fluorogenic sensors with suitable kinetic parameters and sensitivity have been developed for the determination of sphingosine-1-phosphate lyase activity in cell lysates. The probe RBM148 can be efficiently loaded into cationic liposomes and used to determine S1PL activity in intact cells.

[1]  K. Schwarz,et al.  Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency , 2017, The Journal of clinical investigation.

[2]  L. Metherell,et al.  Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome , 2017, The Journal of clinical investigation.

[3]  H. Wood,et al.  Demyelinating disease: NMO spectrum disorders: clinical or molecular classification? , 2016, Nature Reviews Neurology.

[4]  J. Casas,et al.  Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors. , 2016, Bioorganic & medicinal chemistry.

[5]  J. Casas,et al.  Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase). , 2016, Chemistry and physics of lipids.

[6]  S. Spiegel,et al.  Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. , 2015, Experimental cell research.

[7]  F. Schumacher,et al.  Method to simultaneously determine the sphingosine 1-phosphate breakdown product (2E)-hexadecenal and its fatty acid derivatives using isotope-dilution HPLC-electrospray ionization-quadrupole/time-of-flight mass spectrometry. , 2014, Analytical chemistry.

[8]  C. Beerli,et al.  Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis. , 2014, Journal of medicinal chemistry.

[9]  J. Seco,et al.  Assignment of the absolute configuration of polyfunctional compounds by NMR using chiral derivatizing agents. , 2012, Chemical reviews.

[10]  Bangguo Wei,et al.  A facile approach to trans-4,5-pyrrolidine lactam and application in the synthesis of nemonapride and streptopyrrolidine , 2011 .

[11]  M. Grütter,et al.  Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism. , 2010, Structure.

[12]  C. Bedia,et al.  Synthesis of a Fluorogenic Analogue of Sphingosine‐1‐Phosphate and Its Use to Determine Sphingosine‐1‐Phosphate Lyase Activity , 2009, Chembiochem : a European journal of chemical biology.

[13]  J. Saba,et al.  Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. , 2007, Trends in molecular medicine.

[14]  S. Katsumura,et al.  Versatile synthetic method for sphingolipids and functionalized sphingosine derivatives via olefin cross metathesis. , 2006, Organic letters.

[15]  S. Krishnamurthy.  The principle of vinylogy , 1982 .